Discovery may lead to targeted heart disease treatments

May 8, 2012

University of Guelph researchers have found the location and effect of abnormal heart proteins that can cause cardiac failure, a discovery that points to potential new ways to treat the most costly health problem in the world.

The study appears today in , a peer-reviewed international journal published by the Public Library of Science.

"In order to cure heart disease, you have to understand its fundamental properties," said study author John Dawson, a professor.

"So we looked at variants of naturally occurring proteins that are found in people with heart disease."

The research team included graduate students Maureen Mundia, Ryan Demers, Melissa Chow and Alexandru Perieteanu.

Heart disease and stroke is the leading cause of death in Canada, killing tens of thousands each year. Treating cardiovascular disease costs more than $20 billion a year in physician and hospital costs, lost wages and reduced productivity.

The study examined gene abnormalities for the actin protein and its role in .

As the most abundant protein in the body, actin helps in vital processes including muscle movement.

Abnormal actin genes are linked to heart diseases such as hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM). HCM causes excessive thickening of the heart muscle and can lead to . Under DCM, the heart weakens and enlarges, and cannot pump blood efficiently.

Scientists had already linked HCM and DCM to 14 actin gene abnormalities. "But this is the first time that many of these variants have been studied at the molecular level," Dawson said.

Understanding the molecular deficiencies of actin variants is a starting point for figuring out the underlying mechanisms of heart diseases, he said.

The researchers inserted into to make heart muscle proteins for study. Dawson's lab is one of the few in the world able to do this work.

They then mapped where on the abnormalities occurred and their effects. Three were in spots that resulted in problems with heart contractions; three others were in locations that affected stability and efficiency.

Dawson hopes their work will help in developing more targeted treatments.

" has many different forms and variants. If we can design specific therapies that address the precise mechanisms of the things going on — treat the root cause rather than the whole system — then we can improve the quality of life for people."

Dawson belongs to a growing cardiovascular research group at the University of Guelph, one of few such groups worldwide studying cardiovascular disease from single molecules to animal models.

"It makes Guelph a unique place to do this research," he said.

Explore further: Molecular imaging detects signs of genetic heart disease before symptoms arise

More information: The study is available online: http://dx.plos.org/10.1371/journal.pone.0036821

Related Stories

Genetic mutation implicated in 'broken' heart

February 15, 2012

For decades, researchers have sought a genetic explanation for idiopathic dilated cardiomyopathy (DCM), a weakening and enlargement of the heart that puts an estimated 1.6 million Americans at risk of heart failure each year. ...

Recommended for you

Heart attack treatment hypothesis 'busted'

July 6, 2015

Researchers have long had reason to hope that blocking the flow of calcium into the mitochondria of heart and brain cells could be one way to prevent damage caused by heart attacks and strokes. But in a study of mice engineered ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.